The Technology Transfer Office encourages the creation of novel enterprises to support the development and commercialization of innovations developed at Cedars-Sinai Medical Center. Some examples of the Medical Center’s start-up companies are:
ImmunoCellular Therapeutics, Ltd.
A publicly traded for-profit company that is working towards the development of a brain tumor cancer vaccine.
Kiadis Pharma, B.V. (formerly CelMed Biosciences, Inc.)
A for-profit company headquartered in the Netherlands that is working towards the development of small molecule oncology drugs.
Prometheus Laboratories, Inc.
A for-profit company that is working towards, among other things, the development of diagnostic test kits in the field of inflammatory bowel disease.
A business unit of the Medical Center enabling Biotech and Pharma to develop the promise of personalized medicine in IBD.
The Medical Center supports further development of its research and discovery projects and often seeks partners and collaborators for development, funding and/or licensing. Click here to view a list of available technologies for marketing or contact us if you are interested in obtaining further information regarding these opportunities.